May 14, 2026

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

Conexiant

May 14, 2026

When to Choose MRN Over Ultrasound

Proximal location, multi-nerve involvement, and multi-region extent favor MRN; ultrasound retains value for dynamic assessment and metal artifact–limited cases.

Conexiant

May 14, 2026

Tenecteplase Prior to EVT Did Not Improve Stroke Outcomes

Phase 3 trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

Conexiant

May 14, 2026

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma

Conexiant

May 13, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss

Conexiant

May 13, 2026

New Questions Around AI Clinical Records

As healthcare systems expand AI documentation tools, experts warn safeguards and transparency requirements may be weakening.

KFF Health News

May 13, 2026

Chronotherapy Trial Tests Sleep Timing in Adolescents

Two-week chronotherapy trial evaluates circadian phase, sleep duration, and alignment outcomes.

Conexiant

May 12, 2026

Astigmatism Up After COVID Restrictions

Researchers identified delayed corneal changes in schoolchildren that emerged after myopia rates had already increased during the pandemic.

Conexiant

May 11, 2026

New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

Conexiant

May 11, 2026

Bowel Management Reduced Wet Days

Adding urotherapy at treatment initiation was not associated with additional benefit over 12 weeks

Conexiant